Nature Medicine publishes Helus Pharma’s randomized, placebo-controlled phase 2a trial of SPL026 in major depressive disorder - EurekAlert!
Insilico Medicine announces Nature Medicine publication of Phase IIa results evaluating rentosertib, the novel TNIK inhibitor for idiopathic pulmonary fibrosis (IPF) discovered and designed with a pioneering AI approach - EurekAlert!
